Tecvayli 153 mg/1.7 ml, Injektionslösung

7680687470025 CH-68747 Injektionslösung
Tecvayli 153 mg/1.7 ml, Injektionslösung
Tecvayli 153 mg/1.7 ml, Injektionslösung
Tecvayli 153 mg/1.7 ml, Injektionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
01/05/2025
Summary of Product Characteristics
Français
01/05/2025
Summary of Product Characteristics
Italien
01/05/2025

Detailed composition

Substance Quantity Type Category
(N/A)
153.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.43 MG Substance HBESI

Reimbursement information

Public price
CHF 4285.55
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/09/2023

Authorization holder

Janssen-Cilag AG

6300 Zug

Authorization information

Swissmedic authorization number
68747
Drug name
Tecvayli, Injektionslösung
Galenic form
LSINJ
ATC Code
L01FX24
Authorization status
B
Dispensing category
A
First authorization
22/12/2022
Authorization expiration date
30/06/2026
IT Number
07.16.1.
Domain
Human medicine
Field of application
Multiples Myelom

Package details

Description (FR)
TECVAYLI sol inj 153 mg/1.7ml flac 1.7 ml
Description (DE)
TECVAYLI Inj Lös 153 mg/1.7ml Durchstf 1.7 ml
Market launch
22/12/2022
Narcotic (BTM)
No

Other package sizes (1)

TECVAYLI sol inj 30 mg/3ml flac 3 ml
1 DUR
GTIN: 7680687470018
View